NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,542 | -23.0% | 12,151 | +1.8% | 0.01% | -18.2% |
| Q2 2023 | $303,362 | -21.0% | 11,934 | +129.1% | 0.01% | -75.0% |
| Q2 2016 | $384,000 | -22.4% | 5,209 | -40.8% | 0.04% | -18.5% |
| Q1 2016 | $495,000 | -24.2% | 8,794 | -9.0% | 0.05% | -22.9% |
| Q4 2015 | $653,000 | +73.7% | 9,669 | +19.4% | 0.07% | +75.0% |
| Q3 2015 | $376,000 | -14.2% | 8,101 | -0.6% | 0.04% | -2.4% |
| Q2 2015 | $438,000 | +113.7% | 8,151 | +90.4% | 0.04% | +127.8% |
| Q1 2015 | $205,000 | – | 4,281 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |